Evidence map›Paper›PMID 42619731›Full record

ArticlebioRxiv : the preprint server for biology2026

Resolving Immune Lineage and Cell-State Heterogeneity in Human PBMCs via Mass Spectrometry-Based Single-Cell Proteomics.

Samantha A O'Connor, Romell B Gletten, Ritin Sharma, Zoe N Jensen, Brooke Lovell, Krystine Garcia-Mansfield, Lucy Y Ghoda, Bin Zhang, David E Frankhouser, Russell C Rockne and 3 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Samantha A O'ConnorEarly Detection and Prevention Division, Translational Genomics Research Institute, Phoenix, AZ, USA.ORCID 0000-0002-8202-2435
Romell B GlettenEarly Detection and Prevention Division, Translational Genomics Research Institute, Phoenix, AZ, USA.ORCID 0000-0003-0505-764X
Ritin SharmaEarly Detection and Prevention Division, Translational Genomics Research Institute, Phoenix, AZ, USA.ORCID 0000-0001-8365-9916
Zoe N JensenEarly Detection and Prevention Division, Translational Genomics Research Institute, Phoenix, AZ, USA.ORCID 0009-0000-7541-7052
Brooke LovellEarly Detection and Prevention Division, Translational Genomics Research Institute, Phoenix, AZ, USA.ORCID 0009-0008-1023-2186
Krystine Garcia-MansfieldEarly Detection and Prevention Division, Translational Genomics Research Institute, Phoenix, AZ, USA.ORCID 0000-0002-9089-2254
Lucy Y GhodaDepartment of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center, Duarte, CA, USA.ORCID 0000-0002-8212-3586
Bin ZhangDepartment of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center, Duarte, CA, USA.
David E FrankhouserDepartment of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center, Duarte, CA, USA.ORCID 0000-0002-8233-5853
Russell C RockneDepartment of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center, Duarte, CA, USA.ORCID 0000-0002-1557-159X
Jeffrey M TrentBioinnovation and Genome Sciences Division, Translational Genomics Research Institute, Phoenix, AZ, USA.ORCID 0000-0003-0183-4202
Guido MarcucciDepartment of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center, Duarte, CA, USA.ORCID 0000-0002-3983-5908
Patrick PirrotteEarly Detection and Prevention Division, Translational Genomics Research Institute, Phoenix, AZ, USA.ORCID 0000-0003-1360-6039

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI John Charles Williams · 1985 to 2026
$86.3M
NCI NIH HHS P30 CA033572
6 · The paper itself

Abstract

Single-cell proteomics (SCP) currently lacks validated benchmarking standards, and cell annotation often relies on transcriptomic proxies. Unsupervised clustering offers a proxy-free alternative, but its success depends on biological signal outweighing technical variation. In homogeneous samples this is achievable, but in heterogeneous populations, where closely related cell types differ only subtly, technical variation can dominate the clustering and obscure the biology needed for annotation. To address this, we developed an integrated experimental and computational pipeline for protein-level cell annotation and applied it to human PBMCs as an immune-cell test case. We isolated T cells, B cells, monocytes, and NK cells by negative-selection sorting to build a high-fidelity reference. In parallel, unsorted PBMCs from the same donor were processed on a cellenONE and acquired using label-free DIA on an Orbitrap Astral Zoom. Using the labeled reference dataset, we systematically benchmarked normalization, imputation, and clustering methods to assess their effect on cell-type separation. Unsupervised analysis resolved functional subpopulations within each lineage, and a probabilistic SCP classifier trained on these annotations identified the corresponding cell types and states in the unsorted PBMC fraction, validating the pipeline on unenriched, heterogeneous samples. Together, this work delivers an analytically benchmarked SCP workflow that resolves immune lineage and cell-state heterogeneity in human PBMCs and provides a classifier-ready, protein-level reference for immune-cell assignment.

Identifiers

PMID42619731
PMCPMC13484063

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.